Not so long ago, cardiothoracic surgeons were often called to see patients late in the natural history of their disease and asked to consider higher-risk operations. Most surgeons of an earlier era, when routine cases often carried a greater than 5% mortality, were willing to do this. The growth of intense institutional and public scrutiny of 30-day mortality has brought this era to an end. Thi...